HEIDELBERG -- Predisposition to cancer and other diseases, genetic testing, infectious proteins and ubiquitin signalling -- these are some of the topics internationally renowned speakers will tackle at The EMBO Meeting 2013 to be held in Amsterdam, the Netherlands, from 21-24 September 2013.
Sir Michael Stratton, Director of the Wellcome Trust Sanger Institute, Kri Stefnsson, Chief Executive Officer of deCODE Genetics, and Thijn Brummelkamp, Group Leader at the Netherlands Cancer Institute and winner of the 2013 EMBO Gold Medal, will discuss The Future of Cancer Genomics in an exclusive press conference for journalists and science writers from 11-12 am on Monday 23 September.
On the same day, Anne Glover, Chief Scientific Adviser to Jos Manuel Barroso, President of the European Commission, will be talking to journalists in a Meet the Press event at 6.00 pm.
Sessions on epigenetics, vaccines, stem cell signalling and European science policy are also part of the programme for The EMBO Meeting.
The EMBO Meeting first took place in Amsterdam in 2009, when the conference attracted more than 1300 participants from 50 countries. Attendees at this year's meeting will include researchers at all stages of their scientific career. Policy makers, editors, career advisors, journalists, science bloggers and exhibitors from industry will also be attending the conference.
The EMBO Meeting 2013 will offer plenaries and concurrent sessions by first-rate speakers. Media participants will have multiple opportunities to cover news and also gather ideas for future stories:
|Contact: Barry Whyte|
European Molecular Biology Organization